Clinicare Lab LTD
Clinicare Lab LTD was paid $1.23M by Medicaid between Nov 2022 and Dec 2024, across 78 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 29% of everything it billed.
BURR RIDGE, IL 60527
Next to other Clinical Medical Laboratory providers in Illinois
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2022 | 670 | $6K | |
| 2023 | 51,392 | $933K | |
| 2024incomplete | 33,505 | $290K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 29% | 4,950 | 2,894 | $361K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 16% | 5,199 | 2,995 | $198K |
| 84443 | Thyroid stimulating hormone (TSH) | 5.2% | 4,285 | 3,821 | $64K |
| 83970 | 3.9% | 1,692 | 1,494 | $48K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 3.8% | 4,040 | 3,621 | $47K |
| 80053 | Comprehensive metabolic panel | 3.5% | 4,713 | 4,274 | $43K |
| 82607 | 3.2% | 3,491 | 3,143 | $39K | |
| 82746 | 2.8% | 3,229 | 2,914 | $35K | |
| 84439 | 2.5% | 3,795 | 3,438 | $31K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.3% | 5,258 | 4,807 | $28K |
| 80061 | Lipid panel | 2.0% | 4,528 | 4,117 | $25K |
| 86141 | 2.0% | 1,687 | 1,524 | $24K |
66 more codes
| 83036 | Hemoglobin; glycosylated (A1C) | 2.0% | 4,039 | $24K |
| 82728 | 1.5% | 2,514 | $19K | |
| 84481 | 1.4% | 1,752 | $17K | |
| 83550 | 1.3% | 2,037 | $16K | |
| 83735 | 1.3% | 2,546 | $15K | |
| 83540 | 1.2% | 2,585 | $15K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.1% | 326 | $13K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 1.0% | 278 | $12K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 323 | $12K |
| 83690 | <1% | 1,703 | $10K | |
| 82150 | <1% | 1,658 | $10K | |
| 87535 | <1% | 209 | $8K | |
| 81001 | <1% | 3,028 | $8K | |
| 87538 | <1% | 208 | $8K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 731 | $7K |
| 84153 | <1% | 505 | $6K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 153 | $6K |
| 85652 | <1% | 2,497 | $6K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 212 | $5K |
| 86696 | <1% | 300 | $5K | |
| 84550 | <1% | 1,503 | $5K | |
| 82977 | <1% | 1,197 | $5K | |
| 84466 | <1% | 578 | $5K | |
| 86695 | <1% | 364 | $5K | |
| 84480 | <1% | 510 | $4K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 129 | $4K |
| 82570 | <1% | 773 | $3K | |
| 86803 | <1% | 227 | $3K | |
| 82397 | <1% | 237 | $3K | |
| 82043 | <1% | 715 | $3K | |
| 86705 | <1% | 193 | $3K | |
| 80074 | <1% | 69 | $2K | |
| 82784 | <1% | 194 | $2K | |
| 84100 | <1% | 339 | $2K | |
| 86780 | <1% | 122 | $1K | |
| 86592 | <1% | 401 | $1K | |
| 86704 | <1% | 107 | $1K | |
| 87081 | <1% | 249 | $1K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 529 | $1K |
| 84436 | <1% | 173 | $1K | |
| 86709 | <1% | 197 | $974.42 | |
| 84479 | <1% | 149 | $877.29 | |
| 86140 | <1% | 170 | $714.01 | |
| 84270 | <1% | 47 | $676.71 | |
| 86480 | <1% | 13 | $594.79 | |
| 86706 | <1% | 45 | $430.07 | |
| 86708 | <1% | 44 | $367.57 | |
| 83001 | <1% | 18 | $321.85 | |
| 83721 | <1% | 42 | $291.61 | |
| 87070 | <1% | 51 | $281.86 | |
| 82540 | <1% | 67 | $278.27 | |
| 87340 | <1% | 30 | $262.34 | |
| 82533 | <1% | 16 | $215.51 | |
| 84460 | <1% | 48 | $176.11 | |
| 84075 | <1% | 46 | $169.69 | |
| 85651 | <1% | 42 | $162.99 | |
| 82247 | <1% | 47 | $162.29 | |
| 82310 | <1% | 47 | $157.89 | |
| 82565 | <1% | 47 | $157.85 | |
| 84156 | <1% | 71 | $155.18 | |
| 84520 | <1% | 45 | $119.11 | |
| 84702 | <1% | 13 | $106.02 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 13 | $104.78 |
| 82040 | <1% | 24 | $96.25 | |
| 83718 | <1% | 16 | $73.61 | |
| 99072 | 0% | 1,139 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.